These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2330861)

  • 21. A comparison of the effects of quinetholate, lidocaine and procainamide on ouabain-induced ventricular tachycardia and cardiac function.
    Taylor SE; Nash CB
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):279-90. PubMed ID: 677962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of procainamide in patients with ventricular tachyarrhythmias.
    Liem LB; Yee YG; Swerdlow CD; Kates RE
    J Clin Pharmacol; 1988 Nov; 28(11):984-9. PubMed ID: 3243920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation.
    Miura DS; Wynn J; Keefe D; Laux B; Somberg JC
    Am Heart J; 1987 Jan; 113(1):65-9. PubMed ID: 3799443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide.
    Somberg JC; Tepper D; Sacher H; Schwarz J
    Am Heart J; 1987 Jul; 114(1 Pt 1):18-25. PubMed ID: 3111236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Termination of ventricular tachycardia: role of tachycardia cycle length.
    Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME
    Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
    Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
    Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term lorcainide therapy in patients with ventricular tachycardia.
    Somberg J; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am Heart J; 1985 Jan; 109(1):33-40. PubMed ID: 3966330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia.
    Wellens HJ; Bär FW; Lie KI; Düren DR; Dohmen HJ
    Am J Cardiol; 1977 Oct; 40(4):579-85. PubMed ID: 910721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitation of ventricular tachycardia initiation by procainamide during programmed ventricular stimulation in patients with heart failure.
    Stevenson WG; Weiss J; Stevenson LW; Tillisch JH
    J Electrocardiol; 1990 Jan; 23(1):77-83. PubMed ID: 2406361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
    Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
    Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
    Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes.
    Bhandari AK; Au PK; Rahimtoola SH
    Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
    Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A
    Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.
    Swiryn S; Bauernfeind RA; Strasberg B; Palileo E; Iverson N; Levy PS; Rosen KM
    Am Heart J; 1982 Jul; 104(1):43-50. PubMed ID: 7090985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.